top of page

Lenire ®
Tinnitus Treatment 

A revolutionary, clinically-proven treatment device for patients suffering from tinnitus.

Lenire 004.jpg

Lenire at Precision Hearing

Precision Hearing is proud to be one of the UK’s first official providers of the breakthrough Neuromod Devices Ltd Lenire® tinnitus treatment — a clinically proven, innovative therapy designed to help manage and reduce the symptoms of tinnitus.

This advanced home-based device uses cutting-edge neuroscience to support long-term tinnitus relief and improve quality of life. Lenire® combines modern technology with a simple, easy-to-use system, making it a new standard in tinnitus care.

Lenire 021.jpg

Discover personalised tinnitus management and lasting relief.

About the technology

What is Lenire® and how does it work?

Lenire® is a non-invasive, CE-certified tinnitus treatment device, approved for safe use at home under the guidance of a qualified  healthcare professional.

This innovative device uses dual-mode neuromodulation to reduce tinnitus symptoms. It delivers customised sound therapy through wireless headphones while gently stimulating the tongue with mild electrical pulses via its Tonguetip®. Working together, these signals retrain the brain’s response to tinnitus by promoting adaptive neuroplasticity, helping to reduce the perception of tinnitus over time.

A key benefit of Lenire® therapy is its convenience. Designed for home use, the treatment typically involves just two 30-minute sessions per day for a minimum of 10 weeks, making it easy to fit around your daily routine while supporting long-term relief from tinnitus.

Lenire 028.jpg

Swipe to learn more

About the technology

How effective is the treatment?

Lenire® has been extensively tested in large-scale clinical trials involving more than 600 participants, making it one of the most rigorously studied tinnitus treatments available. The results are highly encouraging:

  • 86.2% of treatment-compliant patients reported an improvement in their Tinnitus Handicap Inventory (THI) scores after 12 weeks.

  • 91% of participants maintained long-term benefits 12 months after treatment.

  • On average, patients experienced a 20.3-point reduction in THI scores, equal to a full grade improvement in tinnitus severity.
     

While Lenire® has shown excellent outcomes, it may not be suitable for everyone. That’s why it must be prescribed and overseen by a qualified audiologist.
 

At your tinnitus consultation, we’ll carry out a thorough assessment of your tinnitus and overall hearing health. From there, our expert audiologists will design a tailored Lenire® treatment plan to suit your needs. You’ll also be invited for regular follow-up appointments so we can track your progress, fine-tune your settings, and ensure you get the very best results.

Lenire® Patient Stories

"Salvatore's skills, expertise and dedication to his patients are unparalleled.
His warm and approachable personality truly sets him apart.
He has always made me feel at ease during every visit, taking the time to explain everything in detail and ensuring I was comfortable with my treatment."

Mr Meyohas

What our clients say

Hearing Hub

bottom of page